Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lipid nanoparticle drug delivery tech
Biotech
Generation Bio jettisons 90% of employees, including R&D org
Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find cash to take its lipid nanoparticle tech further.
James Waldron
Aug 13, 2025 5:00am
AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market
Jun 30, 2025 9:45am
NewLimit raises $130M to push liver mRNA med into clinic
May 6, 2025 11:00am
Tune Tx's $175M series B to fund epigenetic HBV therapy's trials
Jan 13, 2025 8:23am
Etherna lands $950M biobucks deal with Kenneth Chien's Dropshot
Jan 9, 2025 1:05pm
Vertex and Orna team up to develop new blood disorder treatments
Jan 7, 2025 7:00am
